Skip to main content
. 2022 Jul 9;35:103105. doi: 10.1016/j.nicl.2022.103105

Fig. 5.

Fig. 5

Abnormalities co-localised in some patients, but not others. a) Abnormalities co-localised in some patients, but not others. b) Of the patients whose abnormalities co-localised (co-localisation 0.95), this was significantly more likely to be driven by co-localised abnormalities in the ipsilateral hemisphere. c) Three example patients are given for whose abnormalities were not co-localised, partially co-localised, and co-localised. d) Both the proportion of abnormal regional volumes and abnormal connections increased as epilepsy duration increased. e) However, the co-localisation of abnormalities did not relate to epilepsy duration.